Geri-kot Tablet
Product Images NDC 57896-454

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Geri-kot (NDC 57896-454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Geri-care Pharmaceutical Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

454 (Gc 454)

This is a drug facts label for Geri-Kot standardized senna concentrate laxative. Each tablet contains 8.6m sennosides and is meant to relieve occasional constipation. Users should not take the tablets for more than one week unless directed by a doctor. It is not advisable to use the laxative when there are abdominal pains, nausea, vomiting, or when there has been a significant change in bowel movement lasting for more than two weeks. Pregnant or breastfeeding women should ask a professional before using the drug. Furthermore, individuals should not exceed eight tablets in 24 hours. The product contains 100 tablets, and the recommended dose for children under the age of 12 is to ask a doctor.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.